Annotations: 1BMO

Domain Annotation: SCOP/SCOPe Classification SCOP Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
A	d1bmoa1	All alpha proteins	EF Hand-like	EF-hand	Osteonectin	C-terminal (EC) domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d1bmoa2	Small proteins	Knottins (small inhibitors, toxins, lectins)	EGF/Laminin	Follistatin (FS) module N-terminal domain, FS-N	Domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d1bmoa3	Small proteins	Kazal-type serine protease inhibitors	Kazal-type serine protease inhibitors	Ovomucoid domain III-like	Domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
B	d1bmob1	All alpha proteins	EF Hand-like	EF-hand	Osteonectin	C-terminal (EC) domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
B	d1bmob2	Small proteins	Knottins (small inhibitors, toxins, lectins)	EGF/Laminin	Follistatin (FS) module N-terminal domain, FS-N	Domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
B	d1bmob3	Small proteins	Kazal-type serine protease inhibitors	Kazal-type serine protease inhibitors	Ovomucoid domain III-like	Domain of BM-40/SPARC/osteonectin	human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
A	SCOP2B Superfamily	EF-hand	8037302	3001983	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	EGF/Laminin-like	8038352	3000412	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	Kazal-type serine protease inhibitors	8038703	3000605	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	Kazal-type serine protease inhibitors	8038703	3000605	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	EF-hand	8037302	3001983	SCOP2B (2022-06-29)
B	SCOP2B Superfamily	EGF/Laminin-like	8038352	3000412	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
A	SPARC_Ca_bdg	e1bmoA1	A: alpha arrays	X: EF-hand	H: EF-hand-related	T: EF-hand	F: SPARC_Ca_bdg	ECOD (1.6)
A	Kazal_2	e1bmoA2	A: few secondary structure elements	X: Kazal-type serine protease inhibitors-like	H: Kazal-type serine protease inhibitors (From Topology)	T: Kazal-type serine protease inhibitors	F: Kazal_2	ECOD (1.6)
A	FOLN_1	e1bmoA3	A: few secondary structure elements	X: EGF-like	H: EGF-related	T: EGF/Laminin	F: FOLN_1	ECOD (1.6)
B	SPARC_Ca_bdg	e1bmoB1	A: alpha arrays	X: EF-hand	H: EF-hand-related	T: EF-hand	F: SPARC_Ca_bdg	ECOD (1.6)
B	Kazal_2	e1bmoB2	A: few secondary structure elements	X: Kazal-type serine protease inhibitors-like	H: Kazal-type serine protease inhibitors (From Topology)	T: Kazal-type serine protease inhibitors	F: Kazal_2	ECOD (1.6)
B	FOLN_1	e1bmoB3	A: few secondary structure elements	X: EGF-like	H: EGF-related	T: EGF/Laminin	F: FOLN_1	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
A	3.30.60.30	Alpha Beta	2-Layer Sandwich	Wheat Germ Agglutinin (Isolectin 2)	domain 1	CATH (4.3.0)
A	1.10.238.10	Mainly Alpha	Orthogonal Bundle	Recoverin	domain 1	CATH (4.3.0)
B	3.30.60.30	Alpha Beta	2-Layer Sandwich	Wheat Germ Agglutinin (Isolectin 2)	domain 1	CATH (4.3.0)
B	1.10.238.10	Mainly Alpha	Orthogonal Bundle	Recoverin	domain 1	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B	PF09289	Follistatin/Osteonectin-like EGF domain (FOLN)	Follistatin/Osteonectin-like EGF domain	Members of this family are predominantly found in osteonectin and follistatin and adopt an EGF-like fold [1,2].	Domain
A, B	PF00050	Kazal-type serine protease inhibitor domain (Kazal_1)	Kazal-type serine protease inhibitor domain	Usually indicative of serine protease inhibitors. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays. Small alpha+beta fold containi ...	Usually indicative of serine protease inhibitors. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays. Small alpha+beta fold containing three disulphides. Alignment also includes a single domain from transporters in the OATP/PGT family Swiss:P46721.	Domain
A, B	PF10591	Secreted protein acidic and rich in cysteine Ca binding region (SPARC_Ca_bdg)	Secreted protein acidic and rich in cysteine Ca binding region	The SPARC_Ca_bdg domain of Secreted Protein Acidic and Rich in Cysteine is responsible for the anti-spreading activity of human urothelial cells. It is rich in alpha-helices. This extracellular calcium-binding domain contains two EF-hands that each c ...	The SPARC_Ca_bdg domain of Secreted Protein Acidic and Rich in Cysteine is responsible for the anti-spreading activity of human urothelial cells. It is rich in alpha-helices. This extracellular calcium-binding domain contains two EF-hands that each coordinates one Ca2+ ion, forming a helix-loop-helix structure that not only drives the conformation of the protein but is also necessary for biological activity. The anti-spreading activity was dependent on the coordination of Ca2+ by a Glu residue at the Z position of EF-hand 2 [1].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B	BM-40	cation binding ion binding binding calcium ion binding metal ion binding small molecule binding extracellular matrix binding collagen binding protein-containing complex binding	multicellular organismal process positive regulation of locomotion regulation of cell motility regulation of cellular process endothelial cell migration positive regulation of biological process positive regulation of cell migration positive regulation of epithelial cell migration tissue migration ameboidal-type cell migration positive regulation of cell motility regulation of cell migration regulation of endothelial cell migration cell migration multicellular organismal process positive regulation of locomotion regulation of cell motility regulation of cellular process endothelial cell migration positive regulation of biological process positive regulation of cell migration positive regulation of epithelial cell migration tissue migration ameboidal-type cell migration positive regulation of cell motility regulation of cell migration regulation of endothelial cell migration cell migration regulation of multicellular organismal process epithelial cell migration cell motility regulation of epithelial cell migration locomotion positive regulation of cellular process regulation of biological process biological regulation epithelium migration regulation of locomotion positive regulation of endothelial cell migration cellular process developmental process anatomical structure morphogenesis regulation of developmental process anatomical structure development cell morphogenesis regulation of cell morphogenesis regulation of anatomical structure morphogenesis negative regulation of biological process angiogenesis regulation of vasculature development multicellular organism development tube morphogenesis system development blood vessel development regulation of multicellular organismal development blood vessel morphogenesis tube development negative regulation of blood vessel morphogenesis negative regulation of developmental process negative regulation of angiogenesis vasculature development circulatory system development negative regulation of vasculature development regulation of angiogenesis anatomical structure formation involved in morphogenesis negative regulation of multicellular organismal process negative regulation of cell population proliferation cell population proliferation endothelial cell proliferation negative regulation of endothelial cell proliferation regulation of endothelial cell proliferation regulation of cell population proliferation negative regulation of cellular process regulation of epithelial cell proliferation epithelial cell proliferation negative regulation of epithelial cell proliferation	membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membrane-bounded organelle cellular anatomical entity intracellular organelle lumen intracellular organelle organelle lumen organelle nuclear periphery nuclear lumen nuclear matrix basement membrane membrane-bounded organelle intracellular anatomical structure nucleus membrane-enclosed lumen intracellular membrane-bounded organelle cellular anatomical entity intracellular organelle lumen intracellular organelle organelle lumen organelle nuclear periphery nuclear lumen nuclear matrix basement membrane cell periphery extracellular matrix external encapsulating structure collagen-containing extracellular matrix cell surface plasma membrane membrane cytoplasm platelet alpha granule membrane intracellular vesicle endomembrane system cytoplasmic vesicle membrane bounding membrane of organelle vesicle membrane cytoplasmic vesicle secretory granule secretory vesicle vesicle organelle membrane platelet alpha granule secretory granule membrane extracellular region vesicle lumen cytoplasmic vesicle lumen secretory granule lumen platelet alpha granule lumen endocytic vesicle lumen endocytic vesicle extracellular space

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B	IPR015369	Follistatin/Osteonectin EGF domain	Domain
A, B	IPR036058	Kazal domain superfamily	Homologous Superfamily
A, B	IPR002350	Kazal domain	Domain
A, B	IPR011992	EF-hand domain pair	Homologous Superfamily
A, B	IPR018247	EF-Hand 1, calcium-binding site	Binding Site
A, B	IPR037641	SPARC, follistatin-like domain	Domain
A, B	IPR003645	Follistatin-like, N-terminal	Domain
A, B	IPR001999	Osteonectin-like, conserved site	Conserved Site
A, B	IPR019577	SPARC/Testican, calcium-binding domain	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B	Pharos: P09486	osteogenesis imperfecta osteogenesis imperfecta type 17 acute myeloid leukemia plasma cell myeloma adrenal cortex carcinoma uremia Hyperalgesia colorectal cancer hepatitis osteogenesis imperfecta type 4 intervertebral disc degenerative disorder kidney disease cirrhosis of liver malignant colon neoplasm ovarian cancer osteogenesis imperfecta osteogenesis imperfecta type 17 acute myeloid leukemia plasma cell myeloma adrenal cortex carcinoma uremia Hyperalgesia colorectal cancer hepatitis osteogenesis imperfecta type 4 intervertebral disc degenerative disorder kidney disease cirrhosis of liver malignant colon neoplasm ovarian cancer thrombocytopenia malignant pancreatic neoplasm mucopolysaccharidosis type 4 Emery-Dreifuss muscular dystrophy nasopharyngeal carcinoma oligodendroglioma glioblastoma ovarian neoplasm adrenal carcinoma pancreatic intraductal papillary-mucinous neoplasm astrocytic tumor juvenile dermatomyositis limb-girdle muscular dystrophy Becker muscular dystrophy pterygium chronic kidney disease subependymal giant cell astrocytoma malignant glioma transitional cell carcinoma coronary artery disease Down syndrome myeloid neoplasm esophageal adenocarcinoma gastric cancer osteochondrodysplasia pancreatic ductal adenocarcinoma pancreatic intraductal papillary-mucinous neoplasm with low grade dysplasia atopic eczema plasma cell neoplasm benign colon neoplasm colorectal carcinoma ulcerative colitis cystic fibrosis medulloblastoma Duchenne muscular dystrophy myocardial ischemia exocrine pancreatic carcinoma gastric carcinoma hepatocellular carcinoma pancreatic intraductal papillary-mucinous carcinoma invasive ductal breast carcinoma large cell medulloblastoma pilocytic astrocytoma atypical teratoid rhabdoid tumor primitive neuroectodermal tumor breast cancer Sjogren syndrome colonic neoplasm malignant ependymoma

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.